Alendronic Acid

Alendronic Acid

SCHEMBL2282829

Cl.NCCCC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+]

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

FDPS

The experimentally established mechanism targets of Alendronic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
FDPS known ✓ P14324 14/20 0.66
PDE3A Q14432 2/20 0.59
LMNA P02545 4/20 0.41
ADRB3 P13945 1/20 0.41
PDE4D Q08499 1/20 0.41
BLM P54132 3/20 0.35
PMP22 Q01453 2/20 0.34
CYP3A4 P08684 1/20 0.34
NFKB1 P19838 1/20 0.34
GGPS1 O95749 7/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alendronic Acid SCHEMBL3389 0.98 FDPS (0.68) FDPSPDE3ALMNAADRB3PDE4D
Alendronic Acid SCHEMBL5973516 0.96 FDPS (0.66) FDPSPDE3ALMNAADRB3PDE4D
Alendronic Acid SCHEMBL4421548 0.96 FDPS (0.66) FDPSPDE3ALMNAADRB3PDE4D
Alendronic Acid SCHEMBL2402213 0.96 FDPS (0.66) FDPSPDE3ALMNAADRB3PDE4D
Alendronic Acid SCHEMBL536413 0.96 FDPS (0.66) FDPSPDE3ALMNAADRB3PDE4D
Alendronic Acid SCHEMBL204536 0.96 FDPS (0.66) FDPSPDE3ALMNAADRB3PDE4D
Alendronic Acid SCHEMBL4279500 0.96 FDPS (0.64) FDPSPDE3ALMNAADRB3PDE4D
Alendronic Acid SCHEMBL4424488 0.94 FDPS (0.63) FDPSPDE3ALMNAADRB3PDE4D
Alendronic Acid SCHEMBL4284355 0.93 FDPS (0.62) FDPSPDE3ALMNAADRB3PDE4D
Alendronic Acid SCHEMBL579002 0.93 FDPS (0.62) FDPSPDE3ALMNAADRB3PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003820-B2 Process for preparing bisphosphonic acids DR. REDDY'S LABORATORIES LIMITED (IN) 2011-08-23 US disclosed
US-20070142636-A1 PROCESS FOR PREPARING BISPHOSPHONIC ACIDS DR. REDDY'S LABORATORIES, INC. 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142636-A1 PROCESS FOR PREPARING BISPHOSPHONIC ACIDS BPGM, PHOSPHO1, PFKFB2 FDPS 19/4885PDE3A 4067/4885LMNA 2354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.